Latest Breaking News On - Covadonga pa - Page 4 : vimarsana.com

Altamira Therapeutics Ltd (NASDAQ:CYTO) Q4 2022 Earnings Call Transcript

Operator: Good morning, and welcome to the Altamira Therapeutics 2022 Results Conference Call.

South koreaUnited statesHong kongCovadonga paJean lachanceThomas meyerWashington university research groupOsteoarthritis research society international world congressExchange commissionAltamira therapeutics ltdInternational financial reporting standardsAltamira therapeuticsCall transcript mayChief executive officerChief operatingPrivate securities litigation reform act

Altamira Therapeutics Positions its Patented SemaPhore mRNA Delivery Platform as Versatile and Efficient Alternative to Lipid Nanoparticles

Altamira Therapeutics Positions its Patented SemaPhore mRNA Delivery Platform as Versatile and Efficient Alternative to Lipid Nanoparticles
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Covadonga paHanson wadeCompany nasdaqSecurities exchangeSecurities exchange commissionAltamira therapeuticsChief operatingSecurities actSecurities exchange actAltamira therapeuticAltamira therapeutic annual reportNat rev matNat biotechnol

Form FWP Altamira Therapeutics Filed by: Altamira Therapeutics Ltd

Form FWP Altamira Therapeutics Filed by: Altamira Therapeutics Ltd
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarcel gremaudSotorasib lumakrasThomas meyerPrader williAdagrasib krazatiCovadonga paSamuel wicklineSecurities exchange commissionDisruptive technology growth opportunitiesResearch developmentCardiovascular sciencesDisetronic groupHow our technology works oligophoreMarket researchAltamira therapeutics ltd

Altamira Therapeutics (CYTO) Files Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

Altamira Therapeutics (CYTO) Files Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCovadonga paSecurities exchange commissionCompany oligophoreAltamira therapeutics ltdSecurities exchangeAmerican cancer societyUnited states patentTrade officeAltamira therapeutic chief operatingInvestigational new drugSecurities actSecurities exchange actAltamira therapeuticAltamira therapeutic annual reportAltamira therapeutics

Altamira Therapeutics to Present at Two Upcoming RNA Therapeutics Conferences in Q1 2023

Altamira Therapeutics to Present at Two Upcoming RNA Therapeutics Conferences in Q1 2023
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomSamuela wicklineCovadonga paSecurities exchange commissionCompany oligophoreCompany oligophore semaphoreAltamira therapeutics ltdSecurities exchangeAltamira therapeuticsLondon februaryBased therapeutics summitBoston marchChief operating officerChief scientific adviser